1. Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma
   Fei Gao et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
2. YAF2 promotes TP53-mediated genotoxic stress response via stabilization of PDCD5
   Soo-Yeon Park et al, 2015, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
3. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress
   Soo-Yeon Park et al, 2015, Cancer Letters CrossRef
4. Cellular functions of programmed cell death 5
   Ge Li et al, 2016, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
5. Knockout of programmed cell death 5 (PDCD5) gene attenuates neuron injury after middle cerebral artery occlusion in mice
   Jianfei Lu et al, 2016, Brain Research CrossRef
6. Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis
   Yanhui Li et al, 2013, Life Sciences CrossRef
7. Expression and clinical significance of the programmed cell death 5 gene and protein in laryngeal squamous cell carcinoma
   Fenglei Xu et al, 2013, Journal of International Medical Research CrossRef
8. Programmed cell death 5 correlates with disease activity and interleukin-17 in serum and synovial fluid of rheumatoid arthritis patients
   Jun-feng WANG et al, 2013, Chinese Medical Journal CrossRef
9. The clinical significance of reduced programmed cell death 5 expression in human gastrointestinal stromal tumors
   FEI GAO et al, 2012, Oncology Reports CrossRef
10. PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells
    GUI-LING FAN et al, 2015, Oncology Letters CrossRef
11. Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis
    WENBIN ZHU et al, 2015, Molecular Medicine Reports CrossRef
12. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway
    Haiyan S Li et al, 2012, Cancer Biology & Therapy CrossRef
13. RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway
    Qian Cheng et al, 2018, Clinical and Experimental Pharmacology and Physiology CrossRef
14. Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo
    Lanlan Wang et al, 2013, Biochemistry and Cell Biology CrossRef
15. Low dose perfluorooctanoate exposure promotes cell proliferation in a human non-tumor liver cell line
    Hongxia Zhang et al, 2016, Journal of Hazardous Materials CrossRef
16. PDCD5 regulates cell proliferation, cell cycle progression and apoptosi
    Penghui Li et al, 2017, Oncology Letters CrossRef
17. PDCD5 negatively regulates autoimmunity by upregulating FOXP3+ regulatory T cells and suppressing Th17 and Th1 responses
    Juan Xiao et al, 2013, Journal of Autoimmunity CrossRef
18. Diagnostic investigations of DKK‐1 and PDCD5 expression levels as independent prognostic markers of human chondrosarcoma
    Mojtaba Zarea et al, 2016, IUBMB Life CrossRef
19. Low Programmed Cell Death 5 Expression is a Prognostic Factor in Ovarian Cancer
    Li Gao et al, 2015, Chinese Medical Journal CrossRef
20. Effect of the HBV whole-X gene on the expression of hepatocellular carcinoma associated proteins
    Yu Zhang et al, 2016, Journal of Microbiology, Immunology and Infection CrossRef
21. Serine/threonine kinase 31 promotes PDCD5‐mediated apoptosis in p53‐dependent human colon cancer cells
    Sungmin Kwak et al, 2019, Journal of Cellular Physiology CrossRef